Commentary Open Access
Volume 2 | Issue 4 | DOI: https://doi.org/10.33696/cardiology.2.025
Coronary Revascularization in the Era of Transcatheter Aortic Valve Replacement: Treat the Patient, Manage the Disease
Pradyumna E Tummala1,*, Cindy L Grines1
- 1Northside Hospital Cardiovascular Institute, Atlanta GA, United States
Corresponding Author
Pradyumna E Tummala, Prad.Tummala@northside.com; petummala@yahoo.com
Received Date: April 14, 2021
Accepted Date: November 08, 2021
Tummala PE, Grines CL. Coronary Revascularization in the Era of Transcatheter Aortic Valve Replacement: Treat the Patient, Manage the Disease. J Clin Cardiol. 2021; 2(4):96-99.
Copyright: © 2021 Tummala PE, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords
Aortic stenosis, Cardiac catheterization, Coronary angiography, Coronary revascularization, Percutaneous coronary intervention (PCI), Transcatheter aortic valve replacement (TAVR)
Recommended Articles
Body Mass Index and Treatment Response in Patients with Cardiac Light-Chain Amyloidosis
Elevated body mass index (BMI) has been associated with an increased risk of cancer and has been shown to have a negative impact on survival in patients with breast, prostate, oral cancer, and leukemia. In plasma cell dyscrasias, obesity has not only been shown to be a risk factor for the development of multiple myeloma, but also has been associated with a higher rate of progression from monoclonal gammopathy of unknown significance (MGUS) to multiple myeloma, and if intervened on, has bee
Cardiac Stem Cell Therapy, Quo Vadis
Cardiovascular disease causes 30% of global mortality and is still the number one cause of death worldwide. A main patho-physiological process is the coronary disease leading to malperfusion and ischemic cardiac disease as well as cardiac infarction.
Left Atrial Dysfunction in Patients with Coronary Slow Flow
In this review address the changes of LA structure and function in patients with CSFP according to our research and existing literature, therefore provide further insight into its clinical significance and pathophysiological mechanisms.
Coronary Revascularization in the Era of Transcatheter Aortic Valve Replacement: Treat the Patient, Manage the Disease
Coronary artery disease continues to be the greatest cause of global mortality. The prevalence of coronary artery disease in patients with severe aortic stenosis varies widely, from 80% in extreme high-risk trials to only 15% in more recent low risk trials.
A Simple Tool to Predict Transradial Access Failure for Coronary Angiography
Based on multiple large clinical trials, the transradial access (TRA) approach has been widely accepted as the preferred method of vascular access for coronary angiography and percutaneous coronary intervention. However, it is not without its limitations and complications.